Multimedia Release

Potential Tuberculosis Therapy Targets the Patient, Not the Bacteria, to Prevent Drug Resistance (3 of 3)

Reports and Proceedings

American Association for the Advancement of Science (AAAS)

Potential Tuberculosis Therapy Targets the Patient, Not the Bacteria, to Prevent Drug Resistance (3 of 3)

image: In mice, activation of SIRT1 reduced lung inflammation during TB (right), compared to infected mice without SIRT1 (left). This material relates to a paper that appeared in the March 24, 2017, issue of Science Immunology, published by AAAS. The paper, by C.Y. Cheng at Agency for Science, Technology and Research (A*STAR) in Singapore, and colleagues was titled, "Host sirtuin 1 regulates mycobacterial immunopathogenesis and represents a therapeutic target against tuberculosis." view more 

Credit: Cheng <i>et al., Sci. Immunol.</i> 2, eaaj1789 (2017)


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.